Skip to content
Return to Home Page
Register or Log in Contact
American Myalgic Encephalomyelitis and
Chronic Fatigue Syndrome Society
Join Us!
  • ABOUT ME/CFS
      • What Is ME/CFS?
      • What Causes ME/CFS?
      • Symptoms of ME/CFS
      • How Many People Have ME/CFS?
      • How Is ME/CFS Diagnosed?
      • Overlapping Conditions
      • Will I Recover?
      • ME/CFS in Adolescents
      • ME/CFS in Children
      • ME/CFS: Facts & Myths
      • FAQs
      • Outbreaks
      • Anesthesia Warning
  • TREATMENT
      • Treatment Overview
      • Pharmaceuticals
      • Supplements
      • Alternative and Complementary Therapies
      • Experimental Treatments
      • Diet
      • Exercise
      • Coping Strategies
      • Pacing
      • Treatment Database
  • GET SUPPORT
    • Organizations
    • Find a Support Group
    • Work and Disability
    • Relationships
    • For Caregivers
    • AMMES Connect
    • Financial Crisis Fund
  • FIND A PHYSICIAN
    • How to Talk to Your Doctor
    • Physician and Clinic Database
  • GET INVOLVED
    • Why We Need Advocacy
    • Advocacy Groups
    • Action Alerts!
    • Volunteer
    • Donate
    • Clinical Trials
  • RESOURCES
    • Blogs
    • Videos and DVDs
    • Books
    • For Clinicians
    • Useful Links
    • News and Research
    • Interviews With Doctors
    • Newsletters
    • COVID-19 and ME/CFS
  • ABOUT US
    • What We Do
    • Who We Are
    • Policies and Disclaimer
    • AMMES By-Laws
    • Privacy Policy

Tag: sciatic-vagal network

Sciatic-Vagal Nerve Stimulation by Electroacupuncture Alleviates Inflammatory Arthritis in Lyme Disease-Susceptible C3H Mice

Abstract:

Lyme disease is caused by Borrelia burgdorferi, and the pathogenesis of the disease is complex with both bacterial and host factors contributing to inflammatory responses. Lyme disease affects different organs including joints and results in arthritis. Immune responses stimulated by B. burgdorferi through toll-like receptors cause infiltration of leukocytes, which produce inflammatory cytokines and facilitate spirochete clearance.

However, arthritic manifestations and chronic fatigue syndrome-like symptoms persist long after completion of antibiotic treatment regimens in a significant number of patients. To counter the effects of inflammation, treatment by non-steroidal anti-inflammatory drugs, hydroxychloroquine, or synovectomy to eradicate inflammatory arthritis in the involved joint could be employed; however, they often have long-term consequences.

Acupuncture has been used for a long time in Asian medicine to diminish pain during various ailments, but the effects and its mechanism are just beginning to be explored. Control of inflammation by neuronal stimulation has been exploited as a systemic therapeutic intervention to arrest inflammatory processes.

Our objective was to determine whether activation of the sciatic-vagal network by electroacupuncture on ST36 acupoint, which is used to control systemic inflammation in experimental models of infectious disorders such as endotoxemia, can also alleviate Lyme arthritis symptoms in mice. This aim was further strengthened by the reports that sciatic-vagal neuronal network stimulation can lead to dopamine production in the adrenal medulla and moderate the production of inflammatory factors.

We first assessed whether electroacupuncture affects spirochete colonization to attenuate Lyme arthritis. Interestingly, bioluminescent B. burgdorferi burden detected by live imaging and qPCR were similar in electroacupuncture- and mock-treated mice, while electroacupuncture induced a lasting anti-inflammatory effect on mice. Despite the discontinuation of treatment at 2 weeks, the simultaneous decrease in neutrophils in the joints and inflammatory cytokine levels throughout the body at 4 weeks suggests a systemic and persistent effect of electroacupuncture that attenuates Lyme arthritis.

Our results suggest that electroacupuncture-mediated anti-inflammatory responses could offer promising healthcare benefits in patients suffering from long-term Lyme disease manifestations.

Source: Akoolo L, Djokic V, Rocha SC, Ulloa L, Parveen N. Sciatic-Vagal Nerve Stimulation by Electroacupuncture Alleviates Inflammatory Arthritis in Lyme Disease-Susceptible C3H Mice. Front Immunol. 2022 Jul 18;13:930287. doi: 10.3389/fimmu.2022.930287. PMID: 35924250; PMCID: PMC9342905. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342905/ (Full text)

Posted in Alternative Treatments, Animals, Overlapping IllnessesTagged 2022, anti-inflammatories, chronic Lyme arthritis, dopamine, electro-acupuncture, Lyme disease, mouse model, sciatic-vagal network, toll-like receptorsLeave a comment
Help us continue our mission!

Breaking News

  • AMMES WANTS YOU!

    AMMES WANTS YOU!

    AMMES needs volunteers! AMMES is actively recruiting volunteers to help AMMES grow and prosper. Fundraising coordinator –  should have experience …Read More »
  • WE WANT TO HELP!

    WE WANT TO HELP!

    Getting help is a priority for people who are ill. This is especially important for ME/CFS patients who have lost their …Read More »
  • Covid and ME/CFS

    Covid and ME/CFS

    Announcement: AMMES has recently added an informational page about COVID-19 and ME/CFS. The page includes physicians’ recommendations regarding the COVID …Read More »
  • Is the RACGP HANDI recommendation of incremental physical activity for chronic fatigue syndrome/myalgic encephalomyelitis harming patients?

    Is the RACGP HANDI recommendation of incremental physical activity for chronic fatigue syndrome/myalgic encephalomyelitis harming patients?

    Opinion: In April 2024, The Royal Australian College of General Practitioners (RACGP) Handbook of Non-Drug Interventions (HANDI)committee published a guideline: …Read More »
  • Plasma proteomic profile reveals persistent immune activation in post-acute sequelae of SARS-CoV-2 infection

    Plasma proteomic profile reveals persistent immune activation in post-acute sequelae of SARS-CoV-2 infection

    Abstract: Plasma proteomic profiling of 92 individuals with Post-Acute Sequelae of SARS-CoV-2 infection (PASC), assessed a mean of 34 months …Read More »
  • Symptom Patterns, Recovery, and Impact of Long COVID: Findings From a Longitudinal Survey

    Symptom Patterns, Recovery, and Impact of Long COVID: Findings From a Longitudinal Survey

    Abstract: Background: Long COVID is a predominantly multisystem, often disabling, condition that develops following SARS-CoV-2 infection. We aimed to characterize …Read More »
  • Identifying post-exertional malaise subtypes: Differentiating physical and mental PEM manifestations

    Identifying post-exertional malaise subtypes: Differentiating physical and mental PEM manifestations

    Abstract: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a chronic illness with post-exertional malaise (PEM) as a key symptom. This study …Read More »
  • A Short-Term Pacing Intervention in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Study in Portugal

    A Short-Term Pacing Intervention in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Study in Portugal

    Abstract: Background and Objectives: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) remains a disease without a curative treatment. Hence, patient healthcare is mostly …Read More »

This site uses functional cookies and external scripts to improve your experience.

Privacy settings

Privacy Settings

This site uses functional cookies and external scripts to improve your experience. Which cookies and scripts are used and how they impact your visit is specified on the left. You may change your settings at any time. Your choices will not impact your visit.

NOTE: These settings will only apply to the browser and device you are currently using.

Google Analytics

This website uses cookies that do not collect personal information but that do help us collect anonymous information about how people use our website. We use Google Analytics for this purpose. Google Analytics generates statistical and other information about website usage by means of cookies, which are stored on users’ computers. The information collected by Google Analytics about usage of our website is not personally identifiable. The data is collected anonymously, stored by Google and used by us to create reports about website usage.

Powered by Cookie Information
Help us continue our mission!
The American ME and CFS Society
ABOUT ME/CFS

  • What Is ME/CFS?
  • What Causes ME/CFS?
  • Symptoms of ME/CFS
  • How Many People Have ME/CFS?
  • How Is ME/CFS Diagnosed?
  • Overlapping Conditions
  • Will I Recover?
  • ME/CFS in Adolescents
  • ME/CFS in Children
  • ME/CFS: Facts & Myths
  • FAQs
  • Outbreaks
  • Anesthesia Warning
TREATMENT

  • Treatment Overview
  • Pharmaceuticals
  • Supplements
  • Alternative and Complementary Therapies
  • Experimental Treatments
  • Diet
  • Exercise
  • Coping Strategies
  • Pacing
  • Treatment Database
GET SUPPORT

  • Organizations
  • Find a Support Group
  • Work and Disability
  • Relationships
  • For Caregivers
  • AMMES Connect
  • Financial Crisis Fund
FIND A PHYSICIAN

  • How to Talk to Your Doctor
  • Physician and Clinic Database
GET INVOLVED

  • Why We Need Advocacy
  • Advocacy Groups
  • Action Alerts!
  • Volunteer
  • Donate
  • Clinical Trials
RESOURCES

  • Blogs
  • Videos and DVDs
  • Books
  • For Clinicians
  • Useful Links
  • News and Research
  • Interviews With Doctors
  • Newsletters
  • COVID-19 and ME/CFS
ABOUT US

  • What We Do
  • Who We Are
  • Policies and Disclaimer
  • AMMES By-Laws
  • Privacy Policy
Join Us
AMMES

The American ME and CFS Society is a 501(c)(3) nonprofit

This site is not intended as a substitute for medical care. The American ME and CFS Society is not responsible or liable for actions taken as a result of the information presented on this website. Please consult a clinician before embarking on any medical treatment, therapy, or program.